Angiotensin-(1-7) in human follicular fluid correlates with oocyte maturation

Hum Reprod. 2017 Jun 1;32(6):1318-1324. doi: 10.1093/humrep/dex072.

Abstract

Study question: Do angiotensin (Ang)-(1-7) levels in human ovarian follicular fluid (FF) correlate with the number and proportion of mature oocytes obtained for IVF?

Summary answer: The present study shows for the first time that Ang-(1-7) levels in human FF correlate with the proportion of mature oocytes collected upon ovarian stimulation for IVF.

What is known already: Ang-(1-7) is an active peptide of the renin-angiotensin system that stimulates oocyte maturation in isolated rabbit and rat ovaries. However, its role in human ovulation remains unexplored.

Study design, size, duration: This was a prospective cohort study including 64 participants from a single IVF center. Sample size was calculated to achieve a statistical power of 80% in detecting 20% differences in the proportion of mature oocytes between groups. The participants were enrolled in the study during six consecutive months.

Participants/materials, setting, methods: Plasma samples were obtained from all subjects at Day 21 of the last menstrual cycle before starting pituitary blockade and controlled ovarian stimulation (COS). Plasma and FF samples were quickly mixed with a protease inhibitor cocktail and stored at -80°C. Ang-(1-7) was quantified in plasma and FF samples by a highly sensitive and specific radioimmunoassay, which was preceded by solid phase extraction, speed vacuum concentration and sample reconstitution in assay buffer. FF Ang-(1-7) levels were stratified into tertiles and the patients of each tertile were compared for COS/IVF outcomes using Kruskal-Wallis ANOVA. Multiple regression analysis was used to adjust correlations for potential confounders. The mRNA encoding for Mas, a receptor for Ang-(1-7), was investigated by real-time PCR in luteinized granulosa cells purified from the FF.

Main results and the role of chance: There was a four-fold increase in plasma Ang-(1-7) after ovulation induction (median 160.9 vs 41.4 pg/ml, P < 0.0001). FF Ang-(1-7) levels were similar to (169.9 pg/ml) but did not correlate with plasma Ang-(1-7) levels (r = -0.05, P = 0.665). Patients at the highest FF Ang-(1-7) tertile had a higher proportion of mature oocytes compared to patients at the lower FF Ang-(1-7) tertile (median 100% vs 70%, P < 0.01). There was a linear correlation between FF Ang-(1-7) and the proportion of mature oocytes (r = 0.380, P < 0.01), which remained significant after adjustment for age and duration of infertility (r = 0.447, P < 0.001). The luteinized granulosa cells expressed Mas receptor mRNA, which was positively correlated to the number of mature oocytes in women with more than three mature oocytes retrieved (r = 0.42, P < 0.01).

Limitations, reasons for caution: This is an observational study, therefore, no causal relationship can be established between Ang-(1-7) and human oocyte maturation. Mas protein expression was not quantified due to limited availability of granulosa cells.

Wider implications of the findings: Since this peptide promotes oocyte maturation in other species, it deserves further investigation as a potential maturation factor to human oocytes.

Study funding and competing interest(s): Research supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG). The authors have nothing to disclose.

Keywords: angiotensin; controlled ovarian stimulation; follicular fluid; oocyte maturation; ovulation induction.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Angiotensin I / agonists*
  • Angiotensin I / blood
  • Angiotensin I / metabolism
  • Blastocyst / cytology
  • Blastocyst / pathology
  • Cohort Studies
  • Family Characteristics
  • Female
  • Fertility Agents, Female / therapeutic use*
  • Fertilization in Vitro
  • Follicular Fluid / drug effects*
  • Follicular Fluid / metabolism
  • Humans
  • Infertility, Female / blood
  • Infertility, Female / metabolism
  • Infertility, Female / pathology
  • Infertility, Female / therapy*
  • Infertility, Male
  • Male
  • Oocyte Retrieval
  • Oogenesis / drug effects*
  • Ovulation Induction*
  • Peptide Fragments / agonists*
  • Peptide Fragments / blood
  • Peptide Fragments / metabolism
  • Prospective Studies
  • Radioimmunoassay
  • Solid Phase Extraction
  • Up-Regulation / drug effects*

Substances

  • Fertility Agents, Female
  • Peptide Fragments
  • Angiotensin I
  • angiotensin I (1-7)